GlassScriptPhysician profile
Dwayne M Griffin
NPI 1699789727
$21,465.54
in general payments reported to CMS, 2019-2025
56 companies · $4,728 in 2025
The $4,728 reported for 2025 was more than what 88% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,440 · 2020: $1,430 · 2021: $2,554 · 2022: $3,180 · 2023: $4,022 · 2024: $4,112 · 2025: $4,728.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,027.93 |
| Education | $833.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $4,820.23 | 2019-2025 | Fasenra, Airsupra, Tezspire |
| Glaxosmithkline, LLC. | $2,695.74 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,696.89 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Jazz Pharmaceuticals INC. | $1,376.76 | 2019-2025 | Xywav |
| Genzyme Corporation | $1,369.98 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,030.99 | 2019-2025 | Dupixent |
| Grifols USA, LLC | $835.94 | 2019-2025 | Prolastin-C Liquid |
| Inspire Medical Systems, INC. | $800.88 | 2023-2025 | Inspire |
| Harmony Biosciences LLC | $781.69 | 2020-2025 | Wakix |
| Amgen INC. | $651.17 | 2021-2025 | Tezspire, Tavneos |
| Actelion Pharmaceuticals US, INC. | $587.41 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Mylan Specialty L.P. | $529.09 | 2019-2024 | Yupelri |
| Insmed, INC. | $525.83 | 2021-2025 | Arikayce, Brinsupri |
| Verona Pharma, INC. | $520.53 | 2025 | Ohtuvayre |
| Resmed Corp | $351.84 | 2019-2025 |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $270.71 | 2023-2025 | Sunosi |
| Merck Sharp & Dohme LLC | $236.78 | 2020-2025 | Keytruda, Belsomra |
| Pulmonx Corporation | $231.54 | 2020-2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Penumbra, INC. | $174.70 | 2023 | Indigo System |
| Takeda Pharmaceuticals U.S.A., INC. | $161.09 | 2020-2025 | Glassia, Trintellix, Hyqvia |
| Electromed, INC. | $156.93 | 2021-2025 | Smartvest |
| Genentech USA, INC. | $134.01 | 2022-2025 | Xolair |
| Philips North America LLC | $119.79 | 2019-2023 | |
| Sunovion Pharmaceuticals INC. | $112.42 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $112.40 | 2020-2022 | |
| United Therapeutics Corporation | $110.73 | 2023-2025 | Tyvaso, Tyvaso |
| Inari Medical, INC. | $88.46 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Eisai INC. | $88.21 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $85.62 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $78.89 | 2022 | |
| Viatris Specialty LLC | $58.63 | 2025 | Yupelri |
| Bayer Healthcare Pharmaceuticals INC. | $56.81 | 2022-2024 | |
| Alexion Pharmaceuticals, INC. | $55.52 | 2019-2021 | |
| Abbvie INC. | $49.73 | 2022 | |
| Advanced Respiratory, INC | $45.67 | 2021 | |
| Pfizer INC. | $37.49 | 2021-2024 | |
| Shire North American Group INC | $35.36 | 2019 | |
| Gilead Sciences, INC. | $34.33 | 2022-2023 | Veklury |
| Inogen, INC. | $32.19 | 2024 | |
| Mallinckrodt Enterprises LLC | $31.42 | 2019 | |
| Janssen Pharmaceuticals, INC | $30.90 | 2019 | |
| Vapotherm INC | $30.49 | 2021 | |
| Idorsia Pharmaceuticals US INC | $22.85 | 2023 | Quviviq |
| Baxter Healthcare | $21.29 | 2022 | |
| Lilly USA, LLC | $20.47 | 2025 | Zepbound |
| Noctrix Health, INC. | $20.20 | 2025 | Nidra |
| Novo Nordisk INC | $17.08 | 2022 | |
| Novartis Pharmaceuticals Corporation | $16.01 | 2019 | |
| Allergan, INC. | $15.69 | 2019 | |
| Boston Scientific Corporation | $15.34 | 2022 | |
| Avadel Cns Pharmaceuticals, LLC | $13.83 | 2024 | Lumryz |
| Adma Biomanufacturing LLC | $13.78 | 2021 | |
| Zoll Respicardia, INC. | $13.50 | 2024 | Remede System |
| Breas Medical, INC. | $13.37 | 2024 | Vivo 45 Ls |
| La Jolla Pharmaceutical Company | $13.23 | 2021 | |
| Circassia INC. | $13.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dwayne Griffin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.